Insomnia Clinical Trials

Find Insomnia Clinical Trials Near You

Improving Insomnia Treatment by Optimizing Timing of rTMS Administration

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Repetitive transcranial magnetic stimulation (rTMS) has shown to be a promising technique for improving insomnia symptoms and sleep quality. However, the impact of circadian rhythmicity on rTMS sessions and its potential influence on insomnia therapy remains unclear. Moreover, the effect of rTMS on objective sleep parameters is not fully established. The objective of this pilot study is to establish key feasibility and preliminary data that would be used for an R-level grant application focused on optimizing rTMS therapy for insomnia. The investigators will acquire feasibility data from ten adults with Insomnia disorder. Participants will receive ten sessions rTMS over two weeks, either in the morning or evening. Sleep parameters will be assessed before, during, and after completion of rTMS and brain cortical excitability will be collected before rTMS treatment. The investigators aim to 1) evaluate the impact of circadian timing of rTMS sessions on subjective and objective sleep outcomes, 2) assess the time course of improvements in sleep outcomes, and 3) examine the association between sleep outcomes and cortical excitability. The overarching goal of this work is to optimize rTMS therapy for insomnia by investigating the impact of circadian timing on rTMS sessions and assessing potential variations in subjective and objective measures of sleep.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 45
Healthy Volunteers: f
View:

• Males and females of any racial or ethnic group, aged 25-45 (inclusive)

• Insomnia diagnosis via the DUKE

• Fluent and literate in English

• Written, informed consent

• Reside within 60 miles of Stanford University

Locations
United States
California
1070 Arastradero Road
RECRUITING
Palo Alto
Contact Information
Primary
Maryam Ahmadi, PhD
maryamahmadi529@gmail.com
9512313891
Backup
Andrea Goldstein Piekarski, PhD
agoldpie@stanford.edu
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 10
Treatments
Experimental: MORNING GROUP
Five participants (21 to 45 years old) experiencing clinically meaningful insomnia symptoms will be enrolled and will receive 10 sessions of right dorsolateral prefrontal cortex (DLPFC) rTMS therapy in the morning over two consecutive weeks.
Experimental: EVENING GROUP
Five participants (21 to 45 years old) experiencing clinically meaningful insomnia symptoms will be enrolled and will receive 10 sessions of right dorsolateral prefrontal cortex (DLPFC) rTMS therapy in the evening over two consecutive weeks.
Related Therapeutic Areas
Sponsors
Leads: Stanford University

This content was sourced from clinicaltrials.gov